Its called rinse and repeat.A failed trajectory to break even,...

Its called rinse and repeat.
A failed trajectory to break even, cash flows, sees the sp CRs lower and lower.
A consolidation raises the SP, tightens the capital, and allows the CRs to start again, discount, and discount the SP again, ballooning the scrip.

It is done to hide the previous history, and present a cleaner structure to new investors.
Sometimes so that it can be marketed beyond penny dreadful appearances.

It shouldnt change the MC, but the problem is that it allows for that next CR to occur at discount.
And one could guess that is in the planning for a CR will follow. Is this what the woeful bridging finance was for ?

The best thing that can occur, is that this tech is bought out by a larger player so that patients can still utilize it.
But when would that happen ? If this stock were to go into administration ? they could acquire it for next to nothing ?

My original interest was for the China expansion deals, but where are they ? Would seem a longer bow than first envisaged.

GLTA.